Literature DB >> 14484505

Trials with the molluscicides Rhodiacid and Bayer 73.

E PAULINI, G CHAIA, J de FREITAS.   

Abstract

Keywords:  CARBONATES/pharmacology; SALICYLAMIDES/pharmacology; SNAILS/pharmacology; THIOUREA/related compounds; ZINC/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 14484505      PMCID： PMC2555721     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  1 in total

1.  Bilharziasis control by application of molluscicides; a review of its present status.

Authors:  E PAULINI
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408
  1 in total
  5 in total

1.  MOLLUSCICIDAL QUALITIES OF BAYLUSCIDE (BAYER 73) REVEALED BY 6-HOUR AND 24-HOUR EXPOSURES AGAINST REPRESENTATIVE STAGES AND SIZES OF AUSTRALORBIS GLABRATUS.

Authors:  L S RITCHIE; L A BERRIOS-DURAN; L P FRICK; I FOX
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

2.  Some laboratory investigations on Bayer 73 and ICI 24223 as molluscicides.

Authors:  A H MEYLING; C H SCHUTTE; R J PITCHFORD
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

3.  [Copper molluscacides in the prophylaxis of bilharziasis].

Authors:  R Deschiens; H Floch; Y Le Corroller
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

4.  Altered Gene Expression in the Schistosome-Transmitting Snail Biomphalaria glabrata following Exposure to Niclosamide, the Active Ingredient in the Widely Used Molluscicide Bayluscide.

Authors:  Si-Ming Zhang; Sarah K Buddenborg; Coen M Adema; John T Sullivan; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

Review 5.  Systematic Review and Meta-analysis of the Impact of Chemical-Based Mollusciciding for Control of Schistosoma mansoni and S. haematobium Transmission.

Authors:  Charles H King; Laura J Sutherland; David Bertsch
Journal:  PLoS Negl Trop Dis       Date:  2015-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.